Financial Performance & Outlook - Cytek's 2024 revenue reached $200.5 million, a 4% year-over-year increase[14] - Adjusted EBITDA for 2024 was $22.4 million, representing a 77% year-over-year growth[14] - The company anticipates revenue between $204 million and $212 million for 2025[11] - Cytek has authorized a $50 million share repurchase program[11] Market Position & Growth - Cytek has placed 3,034 units of its instruments[8] - The company has a broad customer base of approximately 2,000 customers across 70+ countries[8] - The initial total addressable market (TAM) for cell analysis in 2025 is estimated at $7.5 billion[20] - The adjacent TAM is estimated at $8.5 billion[20] Product & Technology - Cytek's FSP (Full Spectrum Profiling) technology underpins its core instruments[28] - Amnis ImageStream revenue experienced 14% growth in 2024[32] - The company's cloud-based operating system has over 16,000 users, with a user base growth of over 160% in 2024[42]